- Home
- KPLT vs XGN Comparison
KPLT vs XGN Comparison
Compare KPLT & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- XGN
- Stock Information
- Founded
- KPLT 2012
- XGN 2002
- Country
- KPLT United States
- XGN United States
- Employees
- KPLT N/A
- XGN N/A
- Industry
- KPLT Diversified Commercial Services
- XGN Medical Specialities
- Sector
- KPLT Consumer Discretionary
- XGN Health Care
- Exchange
- KPLT Nasdaq
- XGN Nasdaq
- Market Cap
- KPLT 49.2M
- XGN 49.4M
- IPO Year
- KPLT N/A
- XGN 2019
- Fundamental
- Price
- KPLT $9.57
- XGN $2.71
- Analyst Decision
- KPLT Hold
- XGN Buy
- Analyst Count
- KPLT 1
- XGN 1
- Target Price
- KPLT $15.00
- XGN $7.00
- AVG Volume (30 Days)
- KPLT 24.0K
- XGN 25.4K
- Earning Date
- KPLT 11-06-2024
- XGN 11-11-2024
- Dividend Yield
- KPLT N/A
- XGN N/A
- EPS Growth
- KPLT N/A
- XGN N/A
- EPS
- KPLT N/A
- XGN N/A
- Revenue
- KPLT $236,293,000.00
- XGN $56,660,000.00
- Revenue This Year
- KPLT $14.79
- XGN $9.98
- Revenue Next Year
- KPLT $12.23
- XGN $13.63
- P/E Ratio
- KPLT N/A
- XGN N/A
- Revenue Growth
- KPLT 14.82
- XGN 7.05
- 52 Week Low
- KPLT $8.26
- XGN $1.30
- 52 Week High
- KPLT $23.54
- XGN $3.71
- Technical
- Relative Strength Index (RSI)
- KPLT 35.50
- XGN 41.39
- Support Level
- KPLT $9.36
- XGN $2.90
- Resistance Level
- KPLT $10.46
- XGN $3.03
- Average True Range (ATR)
- KPLT 0.58
- XGN 0.19
- MACD
- KPLT 0.07
- XGN -0.04
- Stochastic Oscillator
- KPLT 11.79
- XGN 12.80
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc is a technology driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an E-Commerce focused FinTech company offering an innovative lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.